## **Core Concept**
Maternal serum alpha-fetoprotein (MSAFP) screening is a prenatal test used to detect certain fetal abnormalities. Alpha-fetoprotein (AFP) is a protein produced by the liver and yolk sac of a fetus. Abnormal levels of MSAFP can indicate potential issues with fetal development.

## **Why the Correct Answer is Right**
MSAFP screening is primarily used to detect neural tube defects (such as spina bifida and anencephaly) and abdominal wall defects (like gastroschisis and omphalocele). Elevated levels of MSAFP are associated with these conditions. However, decreased levels of MSAFP are linked to chromosomal abnormalities, such as Down syndrome.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Spina bifida is a type of neural tube defect that can be detected through MSAFP screening due to elevated levels of AFP.
- **Option B:** Anencephaly, another neural tube defect, leads to significantly elevated MSAFP levels, making it detectable through this screening method.
- **Option D:** Gastroschisis, an abdominal wall defect, is associated with elevated MSAFP levels, allowing for its detection.

## **Why Option C is Correct (Implicitly)**
- **Option C:** Down syndrome (Trisomy 21) is associated with **decreased** levels of MSAFP, not elevated. This condition is a chromosomal abnormality rather than a structural defect like those mentioned in the other options.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that MSAFP screening is not diagnostic but rather serves as a screening tool. Abnormal results necessitate further diagnostic testing, such as amniocentesis or ultrasound, to confirm the presence of a condition. Additionally, while MSAFP can help identify potential issues, it's crucial to consider the patient's medical history and other risk factors.

## **Correct Answer:** . Down syndrome